Logo image
2.95P Endocrine-associated decoupling of pancreatic function drives glucose intolerance in the mdx mouse model of Duchenne muscular dystrophy
Conference proceeding

2.95P Endocrine-associated decoupling of pancreatic function drives glucose intolerance in the mdx mouse model of Duchenne muscular dystrophy

Angus Lindsay, Gretel Major, Joel Eliades, Jiayi Chen and Charles Najt
Neuromuscular disorders, Vol.67(Supp. 1), 106873
International Congress of the World Muscle Society (WMS) 2026, 31st (Hiroshima, Japan, 29/09/2026–03/10/2026)
29/09/2026
Handle:
https://hdl.handle.net/10523/52756

Abstract

Diabetic-like sequalae are hallmarks of Duchenne muscular dystrophy (DMD). Here, we present a mechanistic framework that identified decoupling of the endocrine-metabolic system in the mdx mouse model of DMD that explains systemic glucose intolerance and metabolic inflexibility. Leveraging behavioural stress hypersensitivity to stimulate transient hepatic-induced hyperglycaemia and exacerbate glucose intolerance, we show that the mdx mouse cannot synthesise appropriate levels of insulin to accommodate fluctuations in systemic glucose. Insulin synthesis and down-stream glucose clearance are impaired due to hyperactivation of the hypothalamic-pituitary-adrenal axis, which were completely overcome with the bilateral removal of the adrenal glands. Ex vivo, isolated pancreatic islets from mdx mice fail to mount a glucose-dependent increase in insulin production, indicating glucose-sensing dysfunction. Despite this pancreatic-intrinsic dysfunction with dystrophin-deficiency, skeletal muscle of mdx mice presented with wildtype-like sensitivity to insulin when it was exogenously administered, which overcame glucose intolerance. These data indicate that a peripheral manipulation of the pancreatic system drives a stress-endocrine bottleneck to disturb metabolic flexibility in DMD.

Metrics

1 Record Views

Details

Logo image